BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1102 related articles for article (PubMed ID: 30357530)

  • 21. Differential Expression of miR-21, miR-23a, and miR-27a, and Their Diagnostic Significance in Egyptian Colorectal Cancer Patients.
    Farouk S; Khairy A; Salem AM; Soliman AF; Bader El Din NG
    Genet Test Mol Biomarkers; 2020 Dec; 24(12):825-834. PubMed ID: 33290159
    [No Abstract]   [Full Text] [Related]  

  • 22. [Relationship of hypoxia-inducible factor 1 alpha (HIF-1alpha) gene expression with vascular endothelial growth factor (VEGF) and microvessel density (MVD) in human colorectal adenoma and adenocarcinoma].
    Jiang CQ; Liu ZS; Qian Q; He YM; Yuan YF; Ai ZL
    Ai Zheng; 2003 Nov; 22(11):1170-4. PubMed ID: 14613646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia-inducible factor-1alpha modulates the down-regulation of the homeodomain protein CDX2 in colorectal cancer.
    Zheng J; Sun X; Wang W; Lu S
    Oncol Rep; 2010 Jul; 24(1):97-104. PubMed ID: 20514449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of miR-217 and HIF-1α/VEGF pathway in patients with diabetic foot ulcer and its effect on angiogenesis of diabetic foot ulcer rats.
    Lin CJ; Lan YM; Ou MQ; Ji LQ; Lin SD
    J Endocrinol Invest; 2019 Nov; 42(11):1307-1317. PubMed ID: 31079353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer.
    Xu L; Li M; Wang M; Yan D; Feng G; An G
    BMC Cancer; 2014 Sep; 14():714. PubMed ID: 25255814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma.
    Kuwai T; Kitadai Y; Tanaka S; Onogawa S; Matsutani N; Kaio E; Ito M; Chayama K
    Int J Cancer; 2003 Jun; 105(2):176-81. PubMed ID: 12673675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
    Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
    Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and significance of PTEN, hypoxia-inducible factor-1 alpha in colorectal adenoma and adenocarcinoma.
    Jiang YA; Fan LF; Jiang CQ; Zhang YY; Luo HS; Tang ZJ; Xia D; Wang M
    World J Gastroenterol; 2003 Mar; 9(3):491-4. PubMed ID: 12632503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
    Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
    Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive Significance of VEGF and HIF-1α Expression in Patients with Metastatic Colorectal Cancer Receiving Chemotherapy Combinations with Bevacizumab.
    Berk V; Deniz K; Bozkurt O; Ozaslan E; Karaca H; Inanc M; Duran AO; Ozkan M
    Asian Pac J Cancer Prev; 2015; 16(14):6149-54. PubMed ID: 26320510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiRNA-451 Inhibits Glioma Cell Proliferation and Invasion Through the mTOR/HIF-1α/VEGF Signaling Pathway by Targeting CAB39.
    Nan Y; Guo H; Guo L; Wang L; Ren B; Yu K; Huang Q; Zhong Y
    Hum Gene Ther Clin Dev; 2018 Sep; 29(3):156-166. PubMed ID: 30180756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.
    Miyoshi J; Toden S; Yoshida K; Toiyama Y; Alberts SR; Kusunoki M; Sinicrope FA; Goel A
    Sci Rep; 2017 Mar; 7():43393. PubMed ID: 28262692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.
    Huang Z; Huang D; Ni S; Peng Z; Sheng W; Du X
    Int J Cancer; 2010 Jul; 127(1):118-26. PubMed ID: 19876917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
    Ma Y; Zhang P; Wang F; Zhang H; Yang J; Peng J; Liu W; Qin H
    Gut; 2012 Oct; 61(10):1447-53. PubMed ID: 22052060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer.
    Yau TO; Wu CW; Tang CM; Chen Y; Fang J; Dong Y; Liang Q; Ng SS; Chan FK; Sung JJ; Yu J
    Oncotarget; 2016 Jan; 7(2):1559-68. PubMed ID: 26621842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas.
    Gattolliat CH; Uguen A; Pesson M; Trillet K; Simon B; Doucet L; Robaszkiewicz M; Corcos L
    Eur J Cancer; 2015 Feb; 51(3):409-20. PubMed ID: 25586944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma.
    Li J; Liu Y; Wang C; Deng T; Liang H; Wang Y; Huang D; Fan Q; Wang X; Ning T; Liu R; Zhang CY; Zen K; Chen X; Ba Y
    Sci Rep; 2015 Aug; 5():12921. PubMed ID: 26250939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression and pathobiological implication of hypoxia-inducible factor-1alpha in human colorectal carcinoma].
    Fan LF; Diao LM; Jiang CQ; Tang ZJ; Xia D; Liu MQ; Liu ZS; Ai ZL
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):242-6. PubMed ID: 15256117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
    Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
    Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
    Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
    Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.